Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Jun 8;7(6):4555-77.
doi: 10.3390/nu7064555.

Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis

Chunla He  1 , Zhoumeng Lin  2 , Sara Wagner Robb  3 , Amara E Ezeamama  4
Affiliations
Meta-Analysis

Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis

Chunla He et al. Nutrients. .

Abstract

Vitamin D deficiency (VDD) is common in women with and without polycystic ovary syndrome (PCOS) and may be associated with metabolic and endocrine disorders in PCOS. The aim of this meta-analysis is to assess the associations of serum vitamin D levels with metabolic and endocrine dysregulations in women with PCOS, and to determine effects of vitamin D supplementation on metabolic and hormonal functions in PCOS patients. The literature search was undertaken through five databases until 16 January 2015 for both observational and experimental studies concerning relationships between vitamin D and PCOS. A total of 366 citations were identified, of which 30 were selected (n = 3182). We found that lower serum vitamin D levels were related to metabolic and hormonal disorders in women with PCOS. Specifically, PCOS patients with VDD were more likely to have dysglycemia (e.g., increased levels of fasting glucose and homeostatic model assessment-insulin resistance index (HOMA-IR)) compared to those without VDD. This meta-analysis found no evidence that vitamin D supplementation reduced or mitigated metabolic and hormonal dysregulations in PCOS. VDD may be a comorbid manifestation of PCOS or a minor pathway in PCOS associated metabolic and hormonal dysregulation. Future prospective observational studies and randomized controlled trials with repeated VDD assessment and better characterization of PCOS disease severity at enrollment are needed to clarify whether VDD is a co-determinant of hormonal and metabolic dysregulations in PCOS, represents a consequence of hormonal and metabolic dysregulations in PCOS or both.

Keywords: metabolic and endocrine disorders; polycystic ovary syndrome; systematic review and meta-analysis; vitamin D.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of literature search.
Figure 2
Figure 2
Forest plots showing the effect size of the association between serum vitamin D levels and PCOS in women (SMD, standardized mean difference; OBS, obese; OVW, overweight; NMW, normal weight; PCOS, polycystic ovary syndrome; CTRL, control.).
See this image and copyright information in PMC

References

    1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (pcos) Hum. Reprod. 2004;19:41–47. - PubMed
    1. Asuncion M., Calvo R.M., San Millan J.L., Sancho J., Avila S., Escobar-Morreale H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected caucasian women from spain. J. Clin. Endocrinol. Metab. 2000;85:2434–2438. doi: 10.1210/jc.85.7.2434. - DOI - PubMed
    1. Diamanti-Kandarakis E., Kouli C.R., Bergiele A.T., Filandra F.A., Tsianateli T.C., Spina G.G., Zapanti E.D., Bartzis M.I. A survey of the polycystic ovary syndrome in the greek island of lesbos: Hormonal and metabolic profile. J. Clin. Endocrinol. Metab. 1999;84:4006–4011. doi: 10.1210/jcem.84.11.6148. - DOI - PubMed
    1. Azziz R., Woods K.S., Reyna R., Key T.J., Knochenhauer E.S., Yildiz B.O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 2004;89:2745–2749. doi: 10.1210/jc.2003-032046. - DOI - PubMed
    1. March W.A., Moore V.M., Willson K.J., Phillips D.I., Norman R.J., Davies M.J. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum. Reprod. 2010;25:544–551. doi: 10.1093/humrep/dep399. - DOI - PubMed